[DIA Recorded Event] Modernizing Regulatory Evidence With Real World Studies 

September 24, 2020

Real world evidence (RWE) is making a larger impact on healthcare across the product lifecycle. Meeting stakeholder requirements requires impactful evidence generated quickly and efficiently through smarter study designs. What is the most appropriate RWE study design for your product?

Join IQVIA’s Nancy Dreyer and Jenny Christian, along with Friends of Cancer Research President and CEO Jeff Allen, in a discussion about the potential of RWE to impact regulatory decision making. They also discuss the complimentary nature of RWE and RCTs using real-life examples. Watch the full event here.


Share This Story!